Patients with mild cases of COVID-19 still have antibodies 11 months after infection and may even have LIFELONG protection, study suggests A new study looked at blood samples from 77 patients who previously had mild cases of COVID-19 Antibody levels…
Read More
Moms report mild to high levels of COVID-19 anxiety and insomnia
Many mothers are experiencing an increase in insomnia severity and mild to high levels of acute COVID-19 anxiety, according to a new study by researchers at Ben-Gurion University of the Negev and The Max Stern Yezreel Valley College in Israel….
Read More
NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19
A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease. Researchers sponsored by the National Institute of Allergy and…
Read More
Europe-wide study of children confirms COVID-19 predominately causes mild disease in children, fatalities are very rare
Children with COVID-19 generally experience a mild disease and fatalities are very rare, according to a study of 582 patients from across Europe published today in The Lancet Child & Adolescent Health journal. The study, which included children and adolescents…
Read More
Rate, timing of altered smell, taste in mild COVID-19 examined
(HealthDay)—Mildly symptomatic patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection often have alterations in smell or taste, according to a research letter published online April 22 in the Journal of the American Medical Association. Giacomo Spinato, M.D., from…
Read More
Most coronavirus infections are mild, says Chinese study
Most people infected by the new coronavirus in China have mild symptoms, with older patients and those with underlying conditions most at risk from the disease, according to a study by Chinese researchers. The disease has now killed nearly 1,900…
Read More